Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to degradable coatings that deliver cells over days, weeks, or months, we can create exclusive hydrogel formulations tailored for each therapeutic application. Likarda is the remarkable culmination of visionary leadership, science that is just as artistic as academic, and a compelling urge to do what’s right. As we move forward, we have well-defined, long-range goals with added opportunities for flexibility and growth.
External link for Likarda
10330 Hickman Mills Dr
Kansas City, Missouri, US
Our President and Founder, Lisa Stehno-Bittel, had such fun hosting the VitalTE team at the Monday night Chief's game. Great game and great people to share it with.
Amazing opportunity to meet with our developing partners Likarda in Kansas City. Stella K. Vnook Matt Virden Lisa Stehno-Bittel Dr. Charles Virden
Likarda reposted this
The last CryoChats™ entitled: 'Cryopreservation of Cell Aggregates and Spheroids', included featured panelist Lisa Stehno-Bittel. Listen to her introduction about the innovative work they do at Likarda. Don't miss next months CryoChats™, 'The Last 100 Yards: Cell and Gene Therapy Clinical Considerations', on Wednesday, December 4th at 2pm ET! 📝 Registration is now open: https://lnkd.in/gUXVHa83 Dominic Clarke, Marty Giedlin, PhD, Jeffrey D. Allen, John Baust, Marc J. Centrella, Scott Fisher, John Bonham-Carter, Mike O'Mara, Priya Baraniak, Ph.D., Russ Straate, Aby J. Mathew, PhD, Adam Joules, Bill Ward, Narayan Bhagroo, Austin Bigley, Dalip Sethi, PhD, MBA, Allison Hubel, PhD, Advitiya Mahajan, Troy Louwagie #Cryopreservation #Biotechnology #ResearchAndDevelopment #CellTherapy #EviaBio #celltherapy #LifeScience
Our CEO, Stella K. Vnook was recently featured in a great read by The Medicine Maker on the future of #cryopreservation in cell and gene therapies. Stella joins other experts to discuss how this technology is transforming healthcare, from advanced therapies to potential space exploration. Cryopreservation plays a critical role in preserving the viability of life-saving treatments, ensuring they reach patients safely and efficiently, and Likarda's work with hydrogels is playing a large part in the advancement of this technology in real time. We’re grateful for the opportunity to contribute to this important conversation and look forward to having many more. 🔗 Check out the full article: https://bit.ly/4hxL0oS #Biotechnology #CellTherapies #HealthcareInnovation
Are you attending Advanced Therapies USA 2024 in Philadelphia? So are we! Our CEO, Stella K. Vnook, and CCO, Shelly Adams, will be there and would love to meet and discuss how Likarda innovations can support your work. Join Stella on Tuesday, November 12th at 5 PM in the Innovation Showcase, where she’ll present Innovating Cell Therapy Delivery: Potential Pathways for Enhanced Regulatory and Patient Outcomes. Don’t miss this opportunity to learn how our breakthroughs are paving the way for improved outcomes in cell therapy. Likarda's hydrogel library is the first and only customizable platform to help you target cell therapies to increase their potency. This breakthrough helps scale cell-based therapies without sacrificing therapeutic quality, paving the way for better outcomes in regenerative medicine. Let's talk about how our patented CSS Technology can help bring success to your therapies! Connect on the conference app or email meetus@likarda.com today! #adtherapiesUSA #advancedtherapies #cellandgenetherapy #biotech
At Likarda, we’re continually pushing the boundaries of innovation to overcome the logistical challenges of cell therapy delivery. Two standout results of this innovation are AegisCell™ and LiberaCell™. AegisCell™ has remarkable potential to protect cells when they must be frozen for storage. In one of our success stories, fresh blood products stored in AegisCell™ on a cooled gel pack maintained high viability for three weeks—something previously unattainable without this advanced encapsulant. This technology not only extends the shelf life of vital cells but also simplifies storage and transport, making the process safer and more cost-effective. LiberaCell™ further enhances logistics by enabling cells to be shipped on dry ice instead of liquid nitrogen, protecting them from ice crystals during the freeze-thaw process. Both hydrogels start with materials familiar to the FDA that can be customized for all cell types, ensuring safety and flexibility in cell therapy logistics. Talk to us to discover how much you can save by using Likarda and eliminating the need for liquid nitrogen in your shipments at Likarda.com. #celltherapy #celldelivery #biotech #cryopreservation
Is Controlled Delivery the Future of Biologics? As biologics continue to revolutionize modern medicine, effective drug delivery remains a significant challenge. In Likarda’s latest white paper, Jordan R. Hunt, PhD explores how hydrogels are emerging as a key solution, offering protection for sensitive molecules, controlled release kinetics, and improved therapeutic outcomes. The paper also covers the benefits, challenges, and real-world applications of integrating hydrogels with biologics. Stay ahead in biotech innovation—read the full white paper now: https://lnkd.in/dBtgaD7P #Biologics #DrugDelivery #Hydrogels #HealthcareInnovation
We are excited to share that our Founder + President, Lisa Stehno-Bittel, will be featured as a panelist at Evia Bio's upcoming CryoChats™ on Wednesday, October 30th, at 2 PM ET. This month’s discussion will focus on an essential topic: 🧊 Cryopreservation of Cell Aggregates and Spheroids. Joining Lisa to discuss ongoing innovations and challenges of this *cool* technology is an esteemed lineup of experts: 🔹 Allison Hubel, PhD – President of the Society for Cryobiology 🔹 Ben Noren – CEO & Co-Founder at CellDrop Biosciences Hosted by: Jeffrey D. Allen – Chairman & CEO at Evia Bio 🔗 Register now: https://lnkd.in/gUXVHa83 We appreciate the opportunity to be a part of this conversation, and can't wait to see what brilliant ideas come from it! #celltherapy #cryochat #cryopreservation #biotechnology
Take action this week with the United States Bone and Joint Initiative! 🦴 Did you know, bone and joint conditions are the most common cause of severe, long-term pain wordwide. For those suffering from osteoarthritis and other bone health issues, therapies like antibodies and stem cells are promising, but delivering them precisely remains a challenge. Likarda's Core-Shell Spherification (CSS) technology solves this by targeting the right site and ensuring the cells stay where needed, promoting faster healing. Additionally, our ViscoCell™ microbeads provide a breakthrough for joint care, improving outcomes in osteoarthritis and similar conditions. Learn more about the ViscoCell™ and the stunning case study results here: https://lnkd.in/gmq6K4U5 #BoneHealth #Osteoporosis #Osteoarthritis #ViscoCell #Likarda #BoneAndJointActionWeek
Last chance to register for our #LikardaKonnect Webinar – happening tomorrow! Don't miss this opportunity to learn from leading experts in hormone replacement therapy. Join us at 11:00 AM EST tomorrow, October 16th, for a game-changing discussion featuring: - Dr. Charles Virden, CEO of VitalTE, sharing expertise on subcutaneous biomechanics. - Dr. Lisa Stehno-Bittel, Founder of Likarda, discussing innovative hormone delivery technologies. Moderated by Dr. Stella K. Vnook , this webinar will be useful to anyone interested in innovations in this exciting and important industry. Register now before it’s too late: https://lnkd.in/g93iXpPq #hormonehealth #hormonereplacement #healthcareinnovation
Team Likarda supported Stephen Harrington and his family entries in the Lenexa Chili Challenge. It was a great night for Francis Karanu, Kami Olson, Aaron Lehman, Jordan R. Hunt, PhD, Lisa Stehno-Bittel and assorted friends. Congratulations to "Life of the Farty" for FIRST PLACE (out of ~ 160 teams) for their amazing Home Style Chili.